Young age is associated with increased rates of residual and recurrent paediatric differentiated thyroid carcinoma.

Despite comparable apparent initial disease burden and treatment, younger children have poorer outcomes when compared to adolescents, even in the absence of nodal metastases and thus may warrant intensification of primary therapy and/or tumour surveillance.